Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Recruiting 3Terminated 2Not yet recruiting 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 36Breast Neoplasms 32Rectal Neoplasms 25Esophageal Neoplasms 21Uterine Cervical Neoplasms 20Head and Neck Neoplasms 20Central Nervous System Neoplasms 19Lung Neoplasms 18Prostatic Neoplasms 17Lymphoma 17Esophageal Squamous Cell Carcinoma 17Leukemia 16Glioblastoma 16Squamous Cell Carcinoma of Head and Neck 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Carcinoma, Hepatocellular 12Sarcoma 10Neuroblastoma 10Neoplasms 10Nasopharyngeal Carcinoma 10Brain Neoplasms 10Astrocytoma 10Colorectal Neoplasms 9Pancreatic Neoplasms 7Glioma 7Neoplasm Metastasis 6Nasopharyngeal Neoplasms 6Lymphoma, Non-Hodgkin 6Stomach Neoplasms 5Recurrence 5

Interventions

Docetaxel 5Pemetrexed 4Capecitabine 4pembrolizumab 3Oxaliplatin 3icotinib 2Radiation 2Paclitaxel 2Gemcitabine 2Gefitinib 2Fluorouracil 2Drug Therapy 2Chemoradiotherapy 2Carboplatin 2sintilimab 1rucaparib 1regorafenib 1olaparib 1lenvatinib 1iron isomaltoside 1000 1ipatasertib 1iopromide 1gluconic acid 1elemene 1capecitabine-irinotecan combination 1aumolertinib 1atezolizumab 1anlotinib 1aflutinib 1XELOX 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma × Radiotherapy × Clear all
NCT00751543 2010-06-29

The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy

National Taiwan University Hospital

Phase NA Unknown
20 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡